Figures 3From: Distinct signatures of the immune responses in low risk versus high risk neuroblastomaHR patients show an increased adaptive immunity compared to LR patients. Flow cytometric analysis of PBMC of patients with HR (n = 3) and LR (n = 1) neuroblastoma.Back to article page